Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 4Unknown 2Recruiting 2Active not recruiting 2Terminated 1Enrolling by invitation 1Available 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1Liver Cirrhosis 1Inflammation 1Frailty 1Carcinoma, Hepatocellular 1

Interventions

Specimen Handling 334Magnetic Resonance Spectroscopy 334Radiotherapy 315Cyclophosphamide 295pembrolizumab 281Cisplatin 267Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 204Bevacizumab 186Gemcitabine 178venetoclax 172Radiosurgery 169Capecitabine 164Oxaliplatin 163fludarabine 161Nivolumab 156Paclitaxel 155Standard of Care 136Surveys and Questionnaires 130Surgical Procedures, Operative 130Dexamethasone 126Fluorouracil 124Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104Azacitidine 101atezolizumab 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × OTHER × epigallocatechin gallate × Clear all
NCT06068543 2026-03-06

ReFOCUS2

University of Rochester

Phase 2 Recruiting
118 enrolled

Frailty, Inflammation

NCT06015022 2025-09-05

CATCH-B

University of Texas Southwestern Medical Center

Phase 2 Recruiting
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡